Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-30

Clinical Trial Update: Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the tolerability and acceptance of two oral hydrocortisone compounding formulations in children with adrenal insuffic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocortisone oral compounding formulation A (Hydrocortisone)
  • Hydrocortisone oral compounding formulation B (Hydrocortisone)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Adrenal Insufficiency | Phase 4 | Status: NOT_YET_RECRUITING